{"id":"W1984252859","doi":"10.1158/0008-5472.sabcs13-p6-10-03","title":"Abstract P6-10-03: Comparative efficacy of everolimus in combination with exemestane and chemotherapy for advanced breast cancer in terms of progression-free survival","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Everolimus; Medicine; Exemestane; Oncology; Internal medicine; Breast cancer; Randomized controlled trial; Progression-free survival; Hazard ratio; Cancer; Meta-analysis; Chemotherapy; Tamoxifen; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004189214,0.0001814485,0.0005878524,0.0003179903,0.00003646637,0.00001131327,0.0001921341,0.00007823402,0.0003403419],"category_scores_gemma":[0.0000464395,0.0001373683,0.00003444118,0.0005611258,0.0005043516,0.0002474471,0.00004917843,0.0002926672,9.354739e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000348469,"about_ca_system_score_gemma":0.0002739053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001217562,"about_ca_topic_score_gemma":0.001047317,"domain_scores_codex":[0.9981278,0.00006919193,0.0003886645,0.0003646717,0.0006163506,0.000433366],"domain_scores_gemma":[0.9984006,0.0003625103,0.0001753063,0.0003433225,0.0006100392,0.0001082388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03676946,0.001621113,0.2395188,0.001751525,0.0002018275,0.00001219621,0.005820558,0.0004473454,0.2351915,0.0001911496,0.0001700698,0.4783045],"study_design_scores_gemma":[0.02246257,0.0007806408,0.9415632,0.002100148,0.000008291883,0.000005824758,0.0005788158,0.0001702259,0.03137996,0.0006695316,0.0001325619,0.0001481608],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937677,0.001041207,0.00002957952,0.0020716,0.00003718182,0.002734405,0.00009498917,0.00001269633,0.0002105792],"genre_scores_gemma":[0.9973083,0.000409866,0.0006614352,0.00002616971,0.0000439032,0.001355826,0.00001246414,0.00003667562,0.0001453581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7020444,"threshold_uncertainty_score":0.5601717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05116332335270693,"score_gpt":0.4282500882082477,"score_spread":0.3770867648555408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}